We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.08%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104B
AUM Growth
+$5.47B
(+5.6%)
Cap. Flow
-$302M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
21.14%
Holding
2,095
New
95
Increased
559
Reduced
924
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HubSpot
HUBS
|
+$449M |
| 2 |
Atlassian
TEAM
|
+$444M |
| 3 |
Microsoft
MSFT
|
+$267M |
| 4 |
Dynatrace
DT
|
+$191M |
| 5 |
ServiceNow
NOW
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$427M |
| 2 |
Republic Services
RSG
|
+$299M |
| 3 |
Marvell Technology
MRVL
|
+$230M |
| 4 |
Lam Research
LRCX
|
+$216M |
| 5 |
CYBR
CyberArk
CYBR
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.77% |
| 2 | Industrials | 15.43% |
| 3 | Healthcare | 11.59% |
| 4 | Financials | 8.09% |
| 5 | Consumer Discretionary | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Infosys
INFY
$51B
| $49.9M | 0.05% |
3,066,545
-872,448
| -22% | -$15M |
|
327
West Pharmaceutical
WST
$24.7B
| $49.9M | 0.05% |
190,113
-20,389
| -10% | -$4.96M |
|
328
Elevance Health
ELV
$84.7B
| $49.8M | 0.05% |
154,171
-29,830
| -16% | -$9.28M |
|
329
Scholar Rock
SRRK
$6.34B
| $49.3M | 0.05% |
1,322,931
+335,467
| +34% | +$11.7M |
|
330
Prudential Financial
PRU
$42.2B
| $48.5M | 0.05% |
467,360
+101,354
| +28% | +$10.7M |
|
331
Deutsche Bank
DB
$71.8B
| $48.4M | 0.05% |
1,374,281
+53,093
| +4% | +$1.81M |
|
332
Enbridge
ENB
$113B
| $48.2M | 0.05% |
955,608
-206
| -0% | -$9.69K |
|
333
BioMarin Pharmaceuticals
BMRN
$13.5B
| $48.2M | 0.05% |
890,213
-203,165
| -19% | -$11.6M |
|
334
3M
MMM
$94.4B
| $48M | 0.05% |
309,256
-6,752
| -2% | -$1.04M |
|
335
PNC Financial Services
PNC
$101B
| $47.9M | 0.05% |
238,401
-7,433
| -3% | -$1.47M |
|
|
336
CALL
Microsoft
MSFT
$3.74T
| $47.6M | 0.05% |
+91,918
| New | +$46.9M |
|
337
W.W. Grainger
GWW
$61.3B
| $47.4M | 0.05% |
49,736
+4,008
| +9% | +$4.02M |
|
338
Agnico Eagle Mines
AEM
$92B
| $47.4M | 0.05% |
281,278
-1,313
| -0.5% | -$180K |
|
339
Albemarle
ALB
$15.3B
| $46.7M | 0.05% |
575,820
-13,330
| -2% | -$1.03M |
|
340
Ventas
VTR
$44.6B
| $46.5M | 0.04% |
664,533
-43,735
| -6% | -$2.94M |
|
341
Valero Energy
VLO
$93.3B
| $45.4M | 0.04% |
266,802
+78,822
| +42% | +$11.8M |
|
342
Travelers Companies
TRV
$78.3B
| $45.3M | 0.04% |
162,292
-528
| -0.3% | -$141K |
|
343
Emcor
EME
$36B
| $44.9M | 0.04% |
69,154
+2,207
| +3% | +$1.34M |
|
344
TransDigm Group
TDG
$68.7B
| $44.8M | 0.04% |
33,987
+7,195
| +27% | +$10.3M |
|
345
CRH
CRH
$67.4B
| $44.4M | 0.04% |
370,584
+45,964
| +14% | +$4.85M |
|
|
AKRO
346
DELISTED
Akero Therapeutics
AKRO
| $44M | 0.04% |
926,441
-60,192
| -6% | -$2.91M |
|
347
Ultragenyx Pharmaceutical
RARE
$2.66B
| $44M | 0.04% |
1,458,187
-241,757
| -14% | -$7.25M |
|
348
Brookfield
BN
$110B
| $44M | 0.04% |
961,341
+35,556
| +4% | +$1.58M |
|
349
Axsome Therapeutics
AXSM
$11.3B
| $44M | 0.04% |
362,138
-49,712
| -12% | -$5.6M |
|
350
Cognizant
CTSH
$26.4B
| $43.7M | 0.04% |
652,207
+37,162
| +6% | +$2.69M |
|
Similar funds
Pictet Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Pictet Asset Management held 2,095 positions worth $104B, up 5.6% from $98.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Pictet Asset Management's Q3 2025 filing shows 95 new, 559 increased, 924 reduced and 64 closed positions. Its largest new stake was Amer Sports: 479,253 shares worth $16.7M. The largest sale was Broadcom, an estimated $427M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q3 2025 buy was Amer Sports: 479,253 shares worth $16.7M.
- Pictet Asset Management added most to HubSpot in Q3 2025, an estimated $449M increase.
- Pictet Asset Management's biggest Q3 2025 reduction was Broadcom, cutting an estimated $427M.
- Pictet Asset Management fully exited Ansys in Q3 2025, selling an estimated $120M.
- Pictet Asset Management's ten largest holdings make up 21% of its $104B portfolio in Q3 2025.
- Pictet Asset Management opened 95 new positions and closed 64 in Q3 2025.
- Pictet Asset Management's portfolio value rose 5.6% quarter-over-quarter to $104B.
Based on Pictet Asset Management's 13F filing for Q3 2025, filed 18 Nov 2025.